Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Clin Microbiol Infect. 2012 Jun 19;19(6):528–536. doi: 10.1111/j.1469-0691.2012.03914.x

Table 3.

Annual costs (in $US millions) associated with CA-MRSA infections and SSTIs only in the US and in the military and jail system sub-populations

Incidence Estimate Third-Party Payer
Perspective
Societal Perspective
All CA-MRSA Infections Annual US Burden
Study 1
 36.4% of Cases are Pediatric 560 (478 – 644) 2,685 (1,621 – 3,464)
 10.1% of Cases are Pediatric 562 (469 – 632) 2,961 (1,494 – 3,989)
Study 2
 36.4% of Cases are Pediatric 1,951 (1,665 – 2,244) 9,350 (5,646 – 12,063)
 10.1% of Cases are Pediatric 1,958 (1,630 – 2,187) 10,311 (5,205 – 13,892)
Study 3
 36.4% of Cases are Pediatric 5,363 (4,577 – 6,169) 25,701 (15,520 – 33,159)
 10.1% of Cases are Pediatric 5,509 (5,159 – 6,011) 28,343 (14,308 – 38,186)

SSTI Annual US Burden^
Study 3
 521 per 100,000* 343 (259 – 451) 393 (312 –503)
Study 4
 164.2 per 100,000* 108 (82 – 142) 124 (98 – 159)
Military
 15 per 1,000* 14 16
 25 per 1,000* 23 26
 35 per 1,000[24] 32 36
Jail System
 10 per 1,000* 6 7
 12 per 1,000* 7 8
 15.84 per 1000[25] 10 11
*

Estimated Incidence

^

83% require I&D